Ichiro Yamauchi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Postmenopausal Women

African American

Top Venues

Clinical endocrinology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin inhibition promotes skeletal growth via the CNP/NPR-B pathway. Endocrinology (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput screening for Cushing disease: therapeutic potential of thiostrepton via cell cycle regulation. Endocrinology (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology 165 (7) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology 165 (7) (2024)
Ichiro Yamauchi, Yoriko Sakane, Yukiko Okuno, Taku Sugawa, Takuro Hakata, Haruka Fujita, Kentaro Okamoto, Daisuke Taura, Takafumi Yamashita, Keisho Hirota, Yohei Ueda, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki
High-throughput Screening in Combination With a Cohort Study for Iodothyronine Deiodinases. Endocrinology 163 (8) (2022)
Ichiro Yamauchi, Yoriko Sakane, Takafumi Yamashita, Takuro Hakata, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Daisuke Taura, Keisho Hirota, Yohei Ueda, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki
Thyroid hormone economy in mice overexpressing iodothyronine deiodinases. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (2) (2022)
Ichiro Yamauchi, Takafumi Yamashita, Taku Sugawa, Tetsuya Tagami, Ikuko Hanaoka, Takeshi Usui, Keisho Hirota, Takuro Hakata, Yohei Ueda, Toshihito Fujii, Yoriko Sakane, Akihiro Yasoda, Nobuya Inagaki
Bezafibrate induces hypothyroidism in a patient with resistance to thyroid hormone β due to a G347R variant. Clinical endocrinology (2021)
Ichiro Yamauchi, Daisuke Taura, Takuro Hakata, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Nobuya Inagaki
Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD-1 blockade therapy. Clinical endocrinology 94 (2) (2020)
Yohei Ueda, Keisho Hirota, Ichiro Yamauchi, Takuro Hakata, Takafumi Yamashita, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki
Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect. PloS one 15 (10) (2020)
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. PloS one 14 (5) (2019)